Andrea Botticelli

12PUBLICATIONS
166CO-AUTHORS
Cancer geneticsPredictive and prognostic markersLiquid biopsiesClinical midwiferyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 07, 2025
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.

Francesca Bonechi, Marina Bacci, Nicla Lorito

|Sep 04, 2025
Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Federica Miglietta, Manon De Graaf, Claudio Vernieri

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Nov 23, 2023
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.

Andrea Botticelli, Roberta Caputo, Simone Scagnoli

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

Pageof 2